Western blot analysis revealed minimal differences in MAPK activity in NRAS versus NRAS-ΔPTEN tumours, whereas the status of the PI3K/PTEN/AKT signalling pathway was significantly different for the two genotypes (Fig. 6). The gene discussed is AKT1; the disease is neoplasm.